# Exacerbations and Their Outcomes International (EXACOS International)

> **NCT04928417** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1762 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04928417
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-26
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 1762 (ACTUAL)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04928417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04928417, "Exacerbations and Their Outcomes International (EXACOS International)". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT04928417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*